One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: A.

Slides:

Advertisements

Similar presentations

Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Characteristics and Long-Term Outcomes of Percutaneous.

Advertisements

From: Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery Ann Intern Med.

The “occasional open heart surgeon” revisited

DES are not Good Enough for Diabetics—CABG will be the Default

Previous coronary stents do not increase early and long-term adverse outcomes in patients undergoing off-pump coronary artery bypass grafting: A propensity-matched.

Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease Ralf.

Total arterial revascularization of triple vessel coronary disease based on combined internal thoracic and radial artery grafts Robert H. Habib, PhD,

Impact of Chronic Kidney Disease on Long-Term Outcomes in Type 2 Diabetic Patients With Coronary Artery Disease on Surgical, Angioplasty, or Medical Treatment

Late survival in abdominal aortic aneurysm patients: The role of selective myocardial revascularization on the basis of clinical symptoms Martha M. Reigel,

Multiple arterial grafts improve survival with coronary artery bypass graft surgery versus conventional coronary artery bypass grafting compared with.

Percutaneous coronary invervention versus coronary artery bypass grafting: A meta- analysis Yolba Smit, MD, MSc, Joan Vlayen, MD, Hetty Koppenaal, MD,

The challenge of achieving 1% operative mortality for coronary artery bypass grafting: A multi-institution Society of Thoracic Surgeons Database analysis

Pre-existing psychological depression confers increased risk of adverse cardiovascular outcomes following cardiac surgery: A systematic review and meta-analysis

Cyrus J. Parsa, MD, Linda K. Shaw, MS, J. Scott Rankin, MD, Mani A

Proteinuria predicts postcardiotomy acute kidney injury in patients with preserved glomerular filtration rate Szu-Yuan Li, MD, Chiao-Lin Chuang, MD,

The long-term impact of diabetes on graft patency after coronary artery bypass grafting surgery: A substudy of the multicenter Radial Artery Patency Study

The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting Danny Chu, MD, Faisal.

Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease Ralf.

Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: A meta-analysis Peter Donndorf, MD, Guenther Kundt, PhD,

Do higher-risk patients benefit from off-pump coronary artery bypass grafting? Evidence from an ecologic analysis of randomized trials Oliver Kuss, PhD,

Fred H. Edwards, MD, David M. Shahian, MD, Maria V

Should clopidogrel be discontinued before coronary artery bypass grafting for patients with acute coronary syndrome? A systematic review and meta-analysis

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies Hisato Takagi,

Peter K. Smith, MD The Journal of Thoracic and Cardiovascular Surgery

Myocardial Revascularization for Patients With Diabetes: Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention? Serenella Castelvecchio,

Shikhar Agarwal, MD, MPH, Aatish Garg, MD, Akhil Parashar, MD, Lars G

Off-Pump Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention: A Meta-Analysis of Randomized and Nonrandomized Studies J. James Edelman,

Juan A. Crestanello, MD, Richard C. Daly, MD

Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.

Lower graft patency after off-pump than on-pump coronary artery bypass grafting: An updated meta-analysis of randomized trials Hisato Takagi, MD, PhD,

Defining operative mortality: Impact on outcome reporting

Why surgery won the SYNTAX trial and why it matters

New-Onset Postoperative Atrial Fibrillation and Long-Term Survival After Aortic Valve Replacement Surgery Giovanni Filardo, PhD, MPH, Cody Hamilton,

Zhe Zheng, MD, PhD, Heng Zhang, MD, PhD, Bo Xu, MBBS

Michael E. Halkos, MD, MSc, Henry A

Coronary artery bypass in patients with type 2 diabetes: Experience from the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial Edward.

Victor van Berkel, MD, PhD

Multilevel data analysis: What? Why? How?

Harold L. Lazar, MD The Journal of Thoracic and Cardiovascular Surgery

Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui,

Off-pump versus on-pump coronary artery bypass grafting: Insights from the Arterial Revascularization Trial Umberto Benedetto, MD, PhD, Douglas G. Altman,

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

Minimally invasive direct coronary artery bypass improves late survival compared with drug-eluting stents in isolated proximal left anterior descending.

The influence of bilateral internal mammary arteries on short- and long-term outcomes: A propensity score matching in accordance with current recommendations

Surgical economics: MACRA, MIPS, and bundles—Lessons learned in the first 3 years of a coronary artery bypass grafting alternative payment model Daniel.

Assessment of coronary artery disease risk in 5463 patients undergoing cardiac surgery: When is preoperative coronary angiography necessary? Nassir M.

Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD

A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned Robert E.

The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation David.

Anaortic off-pump coronary artery bypass grafting: The criterion standard for minimization of neurologic injury J. James Edelman, BSc(Hons), MBBS(Hons),

Angiographic outcomes of radial artery versus saphenous vein in coronary artery bypass graft surgery: A meta-analysis of randomized controlled trials

Do the EXCEL and NOBLE Trial Results Change Meta-Analysis Findings?

Yin-Shu Chang, MD, Jia-Xiang Wang, MD, PhD, Da-Wei Chang, PhD

For everything there is a season

Survival probability loss from percutaneous coronary intervention compared with coronary artery bypass grafting across age groups Umberto Benedetto,

Mild chronic kidney dysfunction and treatment strategies for stable coronary artery disease Neuza Helena Lopes, MD, PhD, Felipe da Silva Paulitsch, MD,

To bypass or stent? The changing rules of an advancing game

Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: A meta-analysis of randomized and nonrandomized.

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

The effect of internal thoracic artery grafts on long-term clinical outcomes after coronary bypass surgery Mark A. Hlatky, MD, David Shilane, PhD, Derek.

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Improved quality and cost-effectiveness of coronary artery bypass grafting in the United States from 1988 to 2005 Howard K. Song, MD, PhD, Brian S. Diggs,

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

Transatlantic editorial: A comparison between European and North American guidelines on myocardial revascularization Philippe Kolh, MD, PhD, Paul Kurlansky,

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements Abby J. Isaacs, MS, Jeffrey Shuhaiber,

Impact of Diabetes on Five-Year Outcomes of Patients With Multivessel Coronary Artery Disease Whady Hueb, MD, Bernard J. Gersh, MB, ChB, Fernando Costa,

Presentation transcript:

One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: A meta-analysis of individual patient data from randomized clinical trials Nestor Mercado, MD, PhD, William Wijns, MD, PhD, Patrick W. Serruys, MD, PhD, Ulrich Sigwart, MD, Marcus D. Flather, MBBS, Rodney H. Stables, DM, William W. O’Neill, MD, Alfredo Rodriguez, MD, Pedro A. Lemos, MD, PhD, Whady A. Hueb, MD, Bernard J. Gersh, MB, ChB, DPhil, Jean Booth, MSc, Eric Boersma, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 130, Issue 2, Pages 512-519 (August 2005) DOI: 10.1016/j.jtcvs.2004.12.049 Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Incidence of adverse cardiovascular events and repeat revascularization procedures during 1-year follow-up in patients allocated to PCI with multiple stenting or CABG surgery (bold line). The Journal of Thoracic and Cardiovascular Surgery 2005 130, 512-519DOI: (10.1016/j.jtcvs.2004.12.049) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Anginal status at 1-year follow-up in patients allocated to PCI with multiple stenting (dark) or CABG surgery (light). The Journal of Thoracic and Cardiovascular Surgery 2005 130, 512-519DOI: (10.1016/j.jtcvs.2004.12.049) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Treatment effects at 1-year follow-up in subgroups of patients. Events represent the 1-year incidence of death, MI, or stroke. Squares represent HRs and 95% CIs. HRs are adjusted for age, gender, previous MI, diabetes mellitus, peripheral vascular disease, hypertension, enrollment diagnosis, number of diseased vessels, ejection fraction, smoking status, aspirin use, β-blocker use, calcium channel blocker use, and long-acting nitrate use. The area of the squares is proportional to the amount of statistical information contributed by the trial (ie, approximately proportional to the number of events). The Journal of Thoracic and Cardiovascular Surgery 2005 130, 512-519DOI: (10.1016/j.jtcvs.2004.12.049) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions